Cryo-Cell International Inc.
CCEL Healthcare Medical Care Facilities
Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024. In the quarter to August 2026, revenue was flat, EPS grew 77.8%, free cash flow fell 58.4% and total debt fell 29.5%, each against the same quarter a year earlier.
Follow CCEL
Cryo-Cell International Inc. (CCEL) Altman Z-score
Cryo-Cell International Inc.'s Altman Z-score for fiscal 2025 is −0.23, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −0.23 | (0.57) |
| FY2024 | 0.34 | 1.05 |
| FY2023 | −0.72 | (1.07) |
| FY2022 | 0.36 | (0.92) |
| FY2021 | 1.27 | (0.13) |
| FY2020 | 1.40 | 0.30 |
| FY2019 | 1.11 | 0.23 |
| FY2018 | 0.88 | (0.32) |
| FY2017 | 1.20 | 1.52 |
| FY2016 | −0.32 | (0.84) |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.13) | — | −0.16 | |
| Retained earnings / total assets | (0.62) | — | −0.87 | |
| EBIT / total assets | 0.01 | — | 0.03 | |
| Market value of equity / total liabilities | 0.43 | — | 0.26 | |
| Sales / total assets | 0.51 | — | 0.51 | |
| Altman Z-score | Distress zone | −0.23 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −3.07 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| BTMD biote Corp. compare | 2.6× |
| JYNT The Joint Corp. compare | 2.4× |
| AIRS AirSculpt Technologies, Inc. compare | 0.9× |
| CCEL Cryo-Cell International Inc. | −0.2× |
| CCM Concord Medical Services Holdings Limited compare | −1.2× |
| PIII P3 Health Partners Inc. compare | −1.3× |
| DCGO DocGo Inc. compare | −1.4× |
| PARK Park Dental Partners, Inc. compare | — |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets